Publications in DiVA – Carina Strell
-
An idiosyncratic zonated stroma encapsulates desmoplastic liver metastases and originates from injured liver
Part of Nature Communications, 2023.
DOI for An idiosyncratic zonated stroma encapsulates desmoplastic liver metastases and originates from injured liver Download full text (pdf) of An idiosyncratic zonated stroma encapsulates desmoplastic liver metastases and originates from injured liver
-
Fibroblast subsets in non-small cell lung cancer: Associations with survival, mutations, and immune features
Part of Journal of the National Cancer Institute, p. 71-82, 2023.
DOI for Fibroblast subsets in non-small cell lung cancer: Associations with survival, mutations, and immune features Download full text (pdf) of Fibroblast subsets in non-small cell lung cancer: Associations with survival, mutations, and immune features
-
Spatial immunophenotyping of the tumour microenvironment in non-small cell lung cancer
Part of European Journal of Cancer, p. 40-52, 2023.
DOI for Spatial immunophenotyping of the tumour microenvironment in non-small cell lung cancer Download full text (pdf) of Spatial immunophenotyping of the tumour microenvironment in non-small cell lung cancer
-
Vessel size as a marker of survival in estrogen receptor positive breast cancer
Part of Breast Cancer Research and Treatment, p. 293-304, 2023.
DOI for Vessel size as a marker of survival in estrogen receptor positive breast cancer Download full text (pdf) of Vessel size as a marker of survival in estrogen receptor positive breast cancer
-
A Novel Pancreatic Cancer Mini-tumor Model to Study Desmoplasia and Myofibroblastic Cancer-Associated Fibroblast Differentiation
Part of Gastro Hep Advances, p. 678-681, 2022.
DOI for A Novel Pancreatic Cancer Mini-tumor Model to Study Desmoplasia and Myofibroblastic Cancer-Associated Fibroblast Differentiation Download full text (pdf) of A Novel Pancreatic Cancer Mini-tumor Model to Study Desmoplasia and Myofibroblastic Cancer-Associated Fibroblast Differentiation
-
Comparison of ROS1-rearrangement detection methods in a cohort of surgically resected non-small cell lung carcinomas.
Part of Translational lung cancer research, p. 2477-2494, 2022.
-
Tumour-infiltrating lymphocytes add prognostic information for patients with low-risk DCIS: findings from the SweDCIS randomised radiotherapy trial
Part of European Journal of Cancer, p. 128-137, 2022.
DOI for Tumour-infiltrating lymphocytes add prognostic information for patients with low-risk DCIS: findings from the SweDCIS randomised radiotherapy trial Download full text (pdf) of Tumour-infiltrating lymphocytes add prognostic information for patients with low-risk DCIS: findings from the SweDCIS randomised radiotherapy trial
-
FGFR1 overexpression in non-small cell lung cancer is mediated by genetic and epigenetic mechanisms and is a determinant of FGFR1 inhibitor response
Part of European Journal of Cancer, p. 136-149, 2021.
DOI for FGFR1 overexpression in non-small cell lung cancer is mediated by genetic and epigenetic mechanisms and is a determinant of FGFR1 inhibitor response Download full text (pdf) of FGFR1 overexpression in non-small cell lung cancer is mediated by genetic and epigenetic mechanisms and is a determinant of FGFR1 inhibitor response
-
High PDGFRb Expression Predicts Resistance to Radiotherapy in DCIS within the SweDCIS Randomized Trial
Part of Clinical Cancer Research, p. 3469-3477, 2021.
-
Infiltration of NK and plasma cells is associated with a distinct immune subset in non‐small cell lung cancer
Part of Journal of Pathology, p. 243-256, 2021.
DOI for Infiltration of NK and plasma cells is associated with a distinct immune subset in non‐small cell lung cancer Download full text (pdf) of Infiltration of NK and plasma cells is associated with a distinct immune subset in non‐small cell lung cancer
-
PD-L1 amplification is associated with an immune cell rich phenotype in squamous cell cancer of the lung
Part of Cancer Immunology and Immunotherapy, p. 2577-2587, 2021.
DOI for PD-L1 amplification is associated with an immune cell rich phenotype in squamous cell cancer of the lung Download full text (pdf) of PD-L1 amplification is associated with an immune cell rich phenotype in squamous cell cancer of the lung
-
TGF-beta-mediated epithelial-mesenchymal transition and tumor-promoting effects in CMT64 cells are reflected in the transcriptomic signature of human lung adenocarcinoma
Part of Scientific Reports, 2021.
DOI for TGF-beta-mediated epithelial-mesenchymal transition and tumor-promoting effects in CMT64 cells are reflected in the transcriptomic signature of human lung adenocarcinoma Download full text (pdf) of TGF-beta-mediated epithelial-mesenchymal transition and tumor-promoting effects in CMT64 cells are reflected in the transcriptomic signature of human lung adenocarcinoma
-
The prognostic impact of the tumour stroma fraction: A machine learning-based analysis in 16 human solid tumour types
Part of EBioMedicine, 2021.
DOI for The prognostic impact of the tumour stroma fraction: A machine learning-based analysis in 16 human solid tumour types Download full text (pdf) of The prognostic impact of the tumour stroma fraction: A machine learning-based analysis in 16 human solid tumour types
-
Blocking PDGF-CC signaling ameliorates multiple sclerosis-like neuroinflammation by inhibiting disruption of the blood-brain barrier
Part of Scientific Reports, 2020.
DOI for Blocking PDGF-CC signaling ameliorates multiple sclerosis-like neuroinflammation by inhibiting disruption of the blood-brain barrier Download full text (pdf) of Blocking PDGF-CC signaling ameliorates multiple sclerosis-like neuroinflammation by inhibiting disruption of the blood-brain barrier
-
Fibroblasts in urothelial bladder cancer define stroma phenotypes that are associated with clinical outcome
Part of Scientific Reports, 2020.
DOI for Fibroblasts in urothelial bladder cancer define stroma phenotypes that are associated with clinical outcome Download full text (pdf) of Fibroblasts in urothelial bladder cancer define stroma phenotypes that are associated with clinical outcome
-
Prognostic Interactions between FAP plus Fibroblasts and CD8a+T Cells in Colon Cancer
Part of Cancers, 2020.
DOI for Prognostic Interactions between FAP plus Fibroblasts and CD8a+T Cells in Colon Cancer Download full text (pdf) of Prognostic Interactions between FAP plus Fibroblasts and CD8a+T Cells in Colon Cancer